X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (780) 780
humans (769) 769
index medicus (701) 701
hypofractionation (685) 685
radiotherapy (684) 684
aged (462) 462
male (447) 447
female (440) 440
middle aged (435) 435
radiology, nuclear medicine & medical imaging (404) 404
cancer (356) 356
dose fractionation (315) 315
radiation-therapy (307) 307
prostate cancer (276) 276
aged, 80 and over (265) 265
treatment outcome (263) 263
hematology, oncology and palliative medicine (261) 261
breast cancer (255) 255
care and treatment (246) 246
dose hypofractionation (234) 234
prostatic neoplasms - radiotherapy (232) 232
randomized-trial (230) 230
radiation (220) 220
adult (219) 219
breast neoplasms - radiotherapy (218) 218
toxicity (214) 214
radiation therapy (211) 211
irradiation (208) 208
uk standardization (180) 180
radiology (164) 164
fractionation (161) 161
patients (158) 158
neoplasm staging (157) 157
intensity-modulated radiotherapy (152) 152
analysis (143) 143
surgery (142) 142
follow-up studies (141) 141
radiotherapy dosage (135) 135
trial (133) 133
carcinoma (128) 128
radiology and nuclear medicine (127) 127
retrospective studies (126) 126
radiotherapy hypofractionation (119) 119
research (119) 119
breast neoplasms - pathology (118) 118
breast neoplasms - surgery (114) 114
chemotherapy (111) 111
prospective studies (109) 109
radiotherapy, intensity-modulated - methods (107) 107
prostatic neoplasms - pathology (96) 96
risk factors (96) 96
medicine & public health (95) 95
survival (94) 94
clinical trials (91) 91
disease-free survival (89) 89
prostate (89) 89
survival rate (88) 88
health aspects (87) 87
neoplasms (87) 87
therapy (85) 85
tumors (85) 85
women (85) 85
conserving surgery (82) 82
lumpectomy (82) 82
radiotherapy, intensity-modulated - adverse effects (79) 79
radiation injuries - etiology (78) 78
usage (78) 78
radiation dose hypofractionation (77) 77
mastectomy, segmental (76) 76
risk (76) 76
external-beam radiotherapy (74) 74
time factors (73) 73
combined modality therapy (72) 72
stereotactic body radiotherapy (71) 71
radiosurgery (69) 69
conformal radiotherapy (67) 67
follow-up (67) 67
mastectomy (67) 67
prognosis (67) 67
radiation doses (67) 67
dose-response relationship, radiation (65) 65
radiotherapy, conformal - methods (65) 65
brachytherapy (64) 64
quality-of-life (64) 64
imrt (63) 63
lung neoplasms - radiotherapy (63) 63
cancer therapies (60) 60
outcomes (59) 59
radiosurgery - methods (59) 59
acute toxicity (57) 57
nuclear radiation (57) 57
quality of life (56) 56
survival analysis (56) 56
oncology, experimental (54) 54
radiotherapy planning, computer-assisted (54) 54
neoplasms. tumors. oncology. including cancer and carcinogens (53) 53
cancer patients (52) 52
radiotherapy, adjuvant (51) 51
feasibility studies (49) 49
patient outcomes (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (995) 995
French (56) 56
German (12) 12
Korean (3) 3
Hungarian (2) 2
Polish (2) 2
Spanish (2) 2
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 1, pp. 435 - 443
Journal Article
Trials, ISSN 1745-6215, 2016, Volume 17, Issue 1, pp. 127 - 127
Pancreatic cancer is the fourth largest cause of cancer death in the United States and Europe with over 100,000 deaths per year in Europe alone. The overall... 
(Borderline) resectable pancreatic cancer | Intention to treat | Overall survival | Explorative laparotomy | Preoperative radiochemotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | PROGNOSTIC-FACTORS | LONG-TERM SURVIVAL | ADENOCARCINOMA | CURATIVE RESECTION | ADJUVANT CHEMORADIATION | CHEMOTHERAPY | PHASE-II TRIAL | THERAPY | CONCURRENT RADIATION | FULL-DOSE GEMCITABINE | Humans | Clinical Protocols | Chemoradiotherapy, Adjuvant - adverse effects | Chemoradiotherapy, Adjuvant - mortality | Antimetabolites, Antineoplastic - administration & dosage | Neoadjuvant Therapy - mortality | Netherlands | Dose Hypofractionation | Time Factors | Deoxycytidine - adverse effects | Pancreatic Neoplasms - mortality | Pancreatectomy - adverse effects | Drug Administration Schedule | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | Tumor Burden | Adenocarcinoma - secondary | Pancreatectomy - mortality | Disease-Free Survival | Adenocarcinoma - therapy | Neoadjuvant Therapy - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Neoplasm Staging | Research Design | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Clinical trials | Care and treatment | Pancreaticoduodenectomy | Pancreatic cancer | Patient outcomes | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1047 - 1060
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2011, Volume 100, Issue 1, pp. 93 - 100
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 10/2018, Volume 140, Issue 1, pp. 75 - 82
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 5, pp. 1271 - 1278
Journal Article
Journal Article
Journal Article